FORT LEE, N.J., March 10 /PRNewswire-FirstCall/ -- Alpharma Inc. announced that the company will release its fourth quarter 2005 earnings after the market close on Monday, March 13, 2006. Alpharma management will conduct a conference call / webcast on Tuesday, March 14, 2006 beginning at 8:30 AM Eastern Standard Time to discuss its fourth quarter results.
The call will be open to all interested parties and may be accessed by using the following information:
CONFERENCE CALL ACCESS Domestic Dial In: (800) 374-0147 International Dial In: (706) 634-5431 Conference Call ID: 5967041
Investors can access the call in a "listen only" mode via the Internet at http://www.streetevents.com or http://www.companyboardroom.com.
In addition, for those unable to participate at the time of the call, a rebroadcast will be available following the call from Tuesday, March 14, 2006 at 12:00 PM Eastern Standard Time until Tuesday, March 21, 2006 at midnight. The rebroadcast may be accessed on the Internet at http://www.streetevents.com or by telephone using the following information:
REBROADCAST ACCESS Domestic Dial In: (800) 642-1687 International Dial In: (706) 645-9291 Participant Code: 5967041
Alpharma Inc. is a global specialty pharmaceutical company with leadership positions in products for humans and animals. Alpharma is presently active in more than 60 countries. Alpharma is a leading manufacturer of generic pharmaceutical products in the U.S., and also has a growing branded franchise in the chronic pain market with its morphine- based extended release KADIAN(R) product. It is also one of the largest suppliers of generic solid dose pharmaceuticals in Europe, with a growing presence in Southeast Asia. The company is a worldwide producer of key active pharmaceutical ingredients. Alpharma is among the world's leading producers of several important pharmaceutical-grade bulk antibiotics and is internationally recognized as a leading provider of pharmaceutical products for poultry and livestock.
Alpharma Inc.CONTACT: Kathleen Makrakis - VP, Investor Relations, Alpharma Inc.,kathleen.makrakis@alpharma.com, +1-201-228-5085
Web site: http://www.alpharma.com/
